Arrow International has initiated a recall of dialysis catheter kits containing Merit Medical Splittable Sheath Introducers due to safety concerns, according to the U.S. Food and Drug Administration. The recall affects medical facilities using these devices for dialysis access procedures.
Medical Device Recalls by Category
FDA device recalls in 2024, by product category
Source: FDA Medical Device Recalls Database, 2024 | Georgian Medical Journal News
Recall Details and Affected Products
The FDA recall notice identifies specific lots of Arrow International dialysis catheter kits that contain the problematic Merit Medical components. Healthcare facilities have been advised to immediately discontinue use of the affected products and return them to the manufacturer.
Arrow International, a subsidiary of Teleflex Medical, manufactures various vascular access devices used in critical care settings. The company has not disclosed the total number of affected units but has confirmed that the recall applies to products distributed nationwide to hospitals and dialysis centers.
For more information on medical device safety, healthcare providers can access additional resources through professional medical networks.
Merit Medical Component Issues
The recalled Merit Medical Splittable Sheath Introducers were found to have defects that could compromise patient safety during dialysis procedures. According to the FDA’s medical device recall database, these components are critical for establishing vascular access in dialysis patients.
Merit Medical Systems, based in Utah, has been working with Arrow International to address the component quality issues. The companies have implemented enhanced quality control measures to prevent similar problems in future product batches.
Healthcare professionals can find updated safety information through the clinical updates section of medical safety databases.
Clinical Impact and Next Steps
Dialysis centers using the recalled catheter kits must implement alternative access methods for affected patients. The Centers for Disease Control and Prevention recommends that facilities maintain adequate inventory of approved vascular access devices to ensure continuity of care.
The recall underscores the importance of robust quality assurance in medical device manufacturing, particularly for products used in life-sustaining treatments like dialysis. Medical device recalls involving dialysis equipment require immediate attention due to the critical nature of these procedures for patient survival.
Healthcare facilities must immediately discontinue use of affected dialysis catheter kits and implement alternative vascular access methods
— FDA Medical Device Recall Notice (FDA, 2024)
Key takeaways
- Arrow International recalled dialysis catheter kits containing defective Merit Medical components
- Healthcare facilities must immediately stop using affected products and return them to manufacturer
- Alternative vascular access methods should be implemented to ensure patient safety during dialysis
Frequently asked questions
Which dialysis catheter kits are affected by this recall?
The recall affects Arrow International dialysis catheter kits containing Merit Medical Splittable Sheath Introducers. Healthcare facilities should check product lot numbers against the FDA recall notice for specific identification.
What should healthcare providers do if they have these products?
Facilities should immediately stop using the affected catheter kits and contact Arrow International for return instructions. Alternative vascular access devices should be used for dialysis procedures.
How can healthcare facilities prevent similar issues?
Regular monitoring of FDA recall notices and maintaining updated inventory management systems can help facilities quickly identify and remove recalled medical devices from clinical use.
The medical device recall highlights ongoing challenges in maintaining quality standards across complex supply chains in healthcare. As dialysis patient populations continue to grow, ensuring the reliability and safety of vascular access devices remains a critical priority for manufacturers, regulators, and healthcare providers working together to protect patient welfare.
Was this article helpful?
Related Coverage
